Sidoti Csr Issues Pessimistic Estimate for USNA Earnings

USANA Health Sciences, Inc. (NYSE:USNA) – Research analysts at Sidoti Csr reduced their Q1 2025 EPS estimates for shares of USANA Health Sciences in a research note issued to investors on Wednesday, February 26th. Sidoti Csr analyst A. Lebiedzinski now anticipates that the company will earn $0.71 per share for the quarter, down from their previous estimate of $0.77. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.45 per share. Sidoti Csr also issued estimates for USANA Health Sciences’ Q2 2025 earnings at $0.60 EPS, Q4 2025 earnings at $0.71 EPS, FY2025 earnings at $2.75 EPS, Q2 2026 earnings at $0.81 EPS and Q4 2026 earnings at $0.92 EPS.

A number of other equities research analysts have also recently commented on USNA. StockNews.com cut shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. DA Davidson dropped their price objective on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a research note on Thursday. Finally, Sidoti cut shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th.

USANA Health Sciences Price Performance

Shares of USANA Health Sciences stock opened at $28.57 on Thursday. The firm has a market cap of $544.54 million, a price-to-earnings ratio of 10.10, a PEG ratio of 0.93 and a beta of 0.87. The stock’s 50-day moving average is $33.50 and its 200 day moving average is $36.56. USANA Health Sciences has a one year low of $27.71 and a one year high of $50.32.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.49 by $0.15. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The company had revenue of $213.61 million for the quarter, compared to analyst estimates of $208.82 million.

Hedge Funds Weigh In On USANA Health Sciences

Several institutional investors have recently bought and sold shares of the company. Pacer Advisors Inc. boosted its holdings in USANA Health Sciences by 16.5% in the 3rd quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock worth $20,638,000 after buying an additional 76,904 shares during the period. Pzena Investment Management LLC lifted its stake in USANA Health Sciences by 7.5% during the third quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock worth $39,801,000 after purchasing an additional 72,977 shares during the last quarter. Dimensional Fund Advisors LP grew its position in USANA Health Sciences by 7.7% during the fourth quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company’s stock valued at $27,751,000 after acquiring an additional 55,059 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its stake in USANA Health Sciences by 14,068.2% in the third quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company’s stock worth $1,472,000 after purchasing an additional 38,547 shares during the last quarter. Finally, Jane Street Group LLC lifted its position in USANA Health Sciences by 330.0% in the fourth quarter. Jane Street Group LLC now owns 39,979 shares of the company’s stock valued at $1,435,000 after purchasing an additional 30,681 shares during the last quarter. Hedge funds and other institutional investors own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.